UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): December 5, 2014
GYRODYNE COMPANY OF AMERICA, INC.
(Exact name of Registrant as Specified in its Charter)
|
New York |
|
000-01684 |
|
11-1688021 |
|
(State or other jurisdiction |
|
(Commission File |
|
(I.R.S. Employer |
|
of incorporation) |
|
Number) |
|
Identification No.) |
ONE FLOWERFIELD
SUITE 24
ST. JAMES, NEW YORK 11780
(Address of principal executive
offices) (Zip Code)
(631) 584-5400
Registrant’s telephone number,
including area code
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01. Regulation FD Disclosure
Frederick C. Braun III, the President and Chief Executive Officer of Gyrodyne Company of America, Inc. (the “Company”) gave a presentation to the Company’s shareholders at its 2014 Annual Shareholders Meeting held on December 5, 2014. The presentation slides are attached hereto as Exhibit 99.1 and is incorporated herein by reference.
The Company is including reconciliations of certain non-GAAP financial measures to the related GAAP financial measures. The reconciliations are attached hereto as Exhibit 99.2.
The information furnished pursuant to Item 7.01, including Exhibits 99.1 and 99.2, shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Securities Exchange Act of 1934.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
|
Exhibit |
|
Exhibit |
|
|
|
|
|
99.1 |
|
Presentation Slides |
|
99.2 |
Non-GAAP Financial Measures Reconciliation |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
GYRODYNE COMPANY OF AMERICA, INC. |
| |
|
|
|
| |
|
|
|
|
|
|
|
By: |
/s/ Frederick C. Braun III |
|
|
|
Frederick C. Braun III |
| |
|
|
President and Chief Executive Officer |
| |
Date: December 5, 2014
2